angioplasty

Nuevas estrategias en el territorio femoropoplíteo

How to Determine Optimal Balloon Size in Below-the-Knee Angioplasty

Unlike the coronary and femoral arteries, calcification of medial layers in infrapatellar arteries prevents positive remodeling and expansion capacity to maintain vessel lumen.&nbsp; Long term patency of endovascular treatment is suboptimal despite the coated balloons, atherectomy devices and stents.&nbsp; Standard angiographies only show vessel lumen far from its real dimension given the severe thickening of<a href="https://solaci.org/en/2020/07/31/how-to-determine-optimal-balloon-size-in-below-the-knee-angioplasty/" title="Read more" >...</a>

La era del stent provisional para las bifurcaciones parece llegar a su fin

IVUS in Unprotected LMCA Angioplasty: Should We Change the Way We Use It?

Courtesy of Dr. Carlos&nbsp;Fava. Bifurcation lesions account for about 25% of all angioplasties and it is a challenge for which there is no single treatment strategy. Intravascular ultrasound (IVUS) has proven its usefulness, improving outcomes by reducing mortality in unprotected left main coronary artery (LMCA) angioplasty. A new strategy consists in conducting an IVUS after<a href="https://solaci.org/en/2020/07/14/ivus-in-unprotected-lmca-angioplasty-should-we-change-the-way-we-use-it/" title="Read more" >...</a>

Nuevas estrategias en el territorio femoropoplíteo

Common Femoral Artery Endarterectomy Plus Angioplasty in Critical Ischemia

This prospective study analyzed patients with critical lower limb ischemia (due to complex, multiple lesions in several places) who were treated uniformly with common femoral artery endarterectomy combined with angioplasty to improve inflow and/or outflow. This hybrid treatment, which must be carried out by a team, can be greatly beneficial for this high-risk patient group<a href="https://solaci.org/en/2020/05/26/common-femoral-artery-endarterectomy-plus-angioplasty-in-critical-ischemia/" title="Read more" >...</a>

¿La elevación de marcadores luego de una angioplastia electiva no debería preocuparnos?

Always in Favor of Primary Angioplasty, Even in the Pandemic Era

Compared with fibrinolytic therapy, reperfusion through primary angioplasty is more reliable and durable, and has less complications. This results in a higher net clinical benefit, both in terms of mortality and of reinfarction and bleeding. In the midst of the COVID-19 pandemic, the discussion on the usefulness of thrombolysis has emerged once again. Some societies<a href="https://solaci.org/en/2020/05/15/always-in-favor-of-primary-angioplasty-even-in-the-pandemic-era/" title="Read more" >...</a>

El uso del ultrasonido intravascular en la angioplastia de tronco no protegido se asocia con mejores resultados en comparación con la angioplastia guiada solo por angiografía.

IVUS in Left Main Coronary Artery Angioplasty: Luxury or Necessity?

Technique advancements in left main coronary artery angioplasty have turned this procedure into a reasonable alternative to surgery, particularly in patients with a low or intermediate Syntax score and, obviously, those in whom surgery was contraindicated. Results can be credited to a refinement in technique, better drug-eluting stents, better patient selection, and frequent use of<a href="https://solaci.org/en/2020/04/15/ivus-in-left-main-coronary-artery-angioplasty-luxury-or-necessity/" title="Read more" >...</a>

Virtual ACC 2020 | PRECOMBAT: 10 Years for Surgery vs. Angioplasty in Left Main Coronary Artery Disease

After 10&nbsp;years of follow-up, there were no significant differences in the rates of major adverse cardiovascular or cerebrovascular events among patients with left main coronary artery disease randomized to angioplasty or surgery. Since this was the first study to randomize patients with left main coronary artery disease to angioplasty or surgery, it enrolled very few<a href="https://solaci.org/en/2020/04/02/virtual-acc-2020-precombat-10-years-for-surgery-vs-angioplasty-in-left-main-coronary-artery-disease/" title="Read more" >...</a>

La ATC es una alternativa válida en el TCI

16 Years of Superiority of Primary Angioplasty

The DANish Acute Myocardial Infarction 2 (DANAMI-2) trial showed the 30-day superiority of patient transport to a primary angioplasty site vs. fibrinolysis at the hospital where the patient had been originally admitted. Those 30-day results became a landmark in the history of interventional cardiology. However, some suspected that such initial benefit could fade away over<a href="https://solaci.org/en/2020/03/27/16-years-of-superiority-of-primary-angioplasty/" title="Read more" >...</a>

Monitoreo Post Angioplastia

Routine Continuous Monitoring After Angioplasty Might Not Be Necessary

According to a recent study published in Circ. Cardiovasc Interv, after a scheduled angioplasty, the rate of arrhythmia requiring some kind of treatment is very low, low enough to deem unnecessary the routine monitoring of all patients. The standard policy at many institutions is continuous cardiac monitoring for several hours after undergoing coronary angioplasty, with<a href="https://solaci.org/en/2020/02/04/routine-continuous-monitoring-after-angioplasty-might-not-be-necessary/" title="Read more" >...</a>

Los balones farmacológicos pasaron la prueba del tiempo en territorio femoropoplíteo

Drug-Coated Balloons vs. Conventional Angioplasty Below the Knee

This meta-analysis is an update on the role of drug-coated balloons in the treatment of infrapopliteal arterial disease, a difficult pathology for all strategies. The primary endpoint of this meta-analysis was treated lower limb salvage at 12&nbsp;months. The secondary endpoints included survival at 12&nbsp;months, amputation free survival, restenosis, and target lesion repeat revascularization rate. This<a href="https://solaci.org/en/2020/01/29/drug-coated-balloons-vs-conventional-angioplasty-below-the-knee/" title="Read more" >...</a>

Nuevas estrategias en el territorio femoropoplíteo

Angioplasty in Long Femoropopliteal Lesions Offers Reasonable Results

Courtesy of Dr. Carlos&nbsp;Fava. Around half the treated lesions in peripheral disease are femoropopliteal lesions. Long lesions are among the challenges faced: they are associated with higher mortality and morbidity, and revascularization in that setting always entails some degree of difficulty. Nowadays, with the development of nitinol stents and more operator experience, angioplasty is becoming<a href="https://solaci.org/en/2020/01/22/angioplasty-in-long-femoropopliteal-lesions-offers-reasonable-results/" title="Read more" >...</a>

Top